Centene announced two key appointments, further aligning company organization structure and operating model with company strategic priorities and accelerating impact to the business and value creation. Sarah London, currently President, Centene Health Care Enterprises and Executive Vice President of Advanced Technology, has been appointed Vice Chairman, Centene Board of Directors. Ms. London will continue to be responsible for Health Care Enterprises and Advanced Technology and will also set strategy and have responsibility for Technology, Business Digitalization, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Enterprise Risk Management. Ms. London will continue to report to Michael Neidorff, Chairman and CEO. Prior to joining Centene, Ms. London served as a Partner for Optum Ventures and Chief Product Officer for Optum Analytics, working on product strategy and expansion. Brent Layton, currently President of Centene U.S. Health plans, Products and International and Executive Vice President, will become President and Chief Operating Officer of Centene. In this enhanced role, he will be responsible for Health Plans, Products, Business Operations, Population Health and Clinical Operations, Marketing, Health Plan Medical, Specialty, International and Business Development. In his 20 years with Centene, Mr. Layton has led the development, implementation and growth of Centene health plans, has played an instrumental role in product design and growth, and has overseen strategic international capabilities. The enhancement of Mr. Layton's role better positions the company for accelerated growth and operational expertise.